TCT 716: Impact of Different Lifetime Management Strategies on Coronary Access: Valve-in-Valve versus TAVR-in-TAVR

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Neovasc